Biopharmacetiucal Approval Trends in 2009 - Biotech approvals were up last year. Is it a sign of a new trend? - BioPharm International

ADVERTISEMENT

Biopharmacetiucal Approval Trends in 2009
Biotech approvals were up last year. Is it a sign of a new trend?


BioPharm International
Volume 23, Issue 10

REFERENCES

1. The future of the biological market. Business insights report. 2010 Mar. Available from: http://www.globalbusinessinsights.com/

2. Carlson B. Biosimilar market fails to meet projections. Gen Eng Biotechnol News. 2009;29:43–5.

3. US Food and Drug Administration. CDER drug and biologic calendar year approvals. 2009 Dec 31. Available from: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/PriorityNDAandBLAApprovals/UCM090995.pdf 4.

4. European Medicines Agency. Available from: http://www.ema.europa.eu/ema

5. Walsh G. Biopharmaceuticals: approvals and approval trends in 2008. Biopharm Int. 2009;22(10):68–77.

6. Walsh G. Biopharmaceuticals: approval trends in 2007. BioPharm Int. 2008;21(10):52–65.

7. Walsh G. Biopharmaceuticals: approval trends in 2006. BioPharm Int. 2007;20(10):56–67.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Novartis Reports Positive Results for Secukinumab in Ankylosing Spondylitis Trials
October 23, 2014
Pall ForteBio Releases Bioprocessing Contamination Detection Kit
October 22, 2014
Roche to Expand and Improve its Basel Site
October 22, 2014
FDA Panel Unanimously Backs Secukinumab for the Treatment of Psoriasis
October 22, 2014
EMA Works to Speed Up Ebola Treatment
October 20, 2014
Author Guidelines
Source: BioPharm International,
Click here